Oaktree Fund Advisors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Oaktree Fund Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Oaktree Fund Advisors from 13F filings

Historical chart of Oaktree Fund Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Oaktree Fund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Oaktree Fund Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 22k 1.19

More positions owned by Oaktree Fund Advisors

Ishares Msci India Etf Etf (INDA)
Anglogold Ashanti Common Stock (AU)
Freeport-mcmoran Common Stock (FCX)
Jd.com Common Stock (JD)
Vale Sa Common Stock (VALE)
Hdfc Bank Common Stock (HDB)
Itau Unibanco Holding Sa Common Stock (ITUB)
Petroleo Brasileiro Sa Common Stock (PBR)
Trip.com Group Common Stock (TCOM)
Yum China Holdings Common Stock (YUMC)
H World Group Common Stock (HTHT)
Infosys Common Stock (INFY)
Pdd Holdings Common Stock (PDD)
Banco Bradesco Sa Common Stock (BBD)
Kanzhun Common Stock (BZ)

View all positions for Oaktree Fund Advisors

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1